Skip to main content

What the FDA labels say about taking them together

Phenytoin and sirolimus

Sirolimus's FDA label of January 28, 2026 names phenytoin in its drug interactions section; the phenytoin labels PlainMeds reads (2) do not name sirolimus. The sirolimus label: “Drugs and other agents that could decrease sirolimus concentrations: Carbamazepine, phenobarbital, phenytoin, rifapentine, St. John’s Wort ( Hypericum perforatum )”

Check it at the source: the phenytoin FDA label on DailyMed (effective October 15, 2024, Mylan Pharmaceuticals Inc.); the sirolimus FDA label on DailyMed (effective January 28, 2026, Glenmark Pharmaceuticals Inc., USA).

What does the phenytoin label say about sirolimus?

Phenytoin's label (effective October 15, 2024) and its 1 other brand-application label do not name sirolimus in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenytek), Mylan Pharmaceuticals Inc., effective October 15, 2024 (SPL set 0f94c791-8b07-4b41-927e-c9f28bec5f60), via openFDA; the full label on DailyMed

What does the sirolimus label say about phenytoin?

Sirolimus label, drug interactions

Drugs and other agents that could decrease sirolimus concentrations: Carbamazepine, phenobarbital, phenytoin, rifapentine, St. John’s Wort ( Hypericum perforatum )

Source: FDA drug label (sirolimus), Glenmark Pharmaceuticals Inc., USA, effective January 28, 2026 (SPL set 57fb4d90-3ccb-4a69-af1e-53be83f7a504), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

29Phenytoin generic labelers
17Sirolimus generic labelers
PhenytoinSirolimus
Labeled forSeizures and epilepsyOrgan transplant rejection
Boxed warningNoYes
Pharmacy cost (NADAC)$0.145 per capsule 100 mg capsule$0.723 per tablet 1 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?